|
|
|
Corporate Profile: Tigris Pharmaceuticals
| Summary: |
| Tigris Pharmaceuticals is focused on drugs targeting key pathways in cancer growth such as p53/apoptosis, angiogenesis, Rho GTPases, PI3K/Akt and survivin. |
| Address: |
3359 Woods Edge Circle
Suite 103
Bonita Springs, FL 34134 |
| Phone
#'s: |
| Main |
(239) 444-5400 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(321) 206-8627 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
